Polypharmacy and possible drug-drug interactions among diabetic patients receiving home health care services

Home Health Care Services Quarterly

Volumn 24, Issue 1-2, 2005, Pages 87-99

  Ibrahim, Ibrahim A ^a   Kang, Eunjeong ^b   Dansky, Kathryn H ^c  

^a BEAUMONT HOSPITAL   (Ireland)

^b Korea Institute for Health and Social Affairs   (South Korea)

^c PENNSYLVANIA STATE UNIVERSITY   (United States)

Author keywords

Diabetes; Drug monitoring; Drug drug interaction; Elderly care; Home health practitioners; Polypharmacy

Indexed keywords

AGED; ARTICLE; DIABETES MELLITUS; DRUG INTERACTION; FEMALE; HOME CARE; HUMAN; MALE; MEDICAL AUDIT; POLYPHARMACY; UNITED STATES;

AGED; AGED, 80 AND OVER; DIABETES MELLITUS; DRUG INTERACTIONS; FEMALE; HOME CARE SERVICES; HUMANS; MALE; MEDICAL AUDIT; MID-ATLANTIC REGION; POLYPHARMACY;

EID: 33644799990     PISSN: 01621424     EISSN: 15450856     Source Type: Journal    
DOI: 10.1300/J027v24n01_07     Document Type: Article

References (30)

1. American Diabetes Association. (1998). Economic consequences of diabetes mellitus in the United States in 1997. Diabetes Care, 21, 296-309.
2. Amery, A. et al. (1978). Glucose intolerance during diuretic therapy. Lancet, 1, 681.
3. Beyth, R.J., & Shorr, R.I. (1999). Epidemiology of adverse drug reactions in the elderly by drug category. Drugs Aging, 14 (3), 231-239.
4. Boyle, J.P., Honeycutt, A.A., VenkatNarayan, K.M., Hoerger, T.J., Geiss, L.S., Chen, H., & Thompson, T.J. (2001). Projection of Diabetes Burden Through 2050: Impact of Changing Demography and Disease Prevalence in the United States. Diabetes Care, 24 (11), 1936-1940.
5. Broderick, E. (1997). Prescribing patterns for nursing home residents in the U.S. The reality and the vision. Drugs & Aging, 11 (4), 255-260.
6. Brown, N.J., Griffin, M.R., Ray, W.A., Meredith, S., Beers, M.H., Marren, J., Robles, M., Stergachis, A., Wood, A.J., and Avorn, J. (1998). A Model for Improving Medication Use in Home Health Care Patients. Journal of the American Pharmaceutical Association, 38, 696-702.
7. Christian, J.B., Lapane, K.L., & Toppa, R.S. (2003). Racial disparities in receipt of secondary stroke prevention agents among U.S. nursing home residents. Stroke, 34 (11), 2693-2697.
8. Cohen, J.S. Avoiding adverse reactions. (2000). Effective lower-dose drug therapies for older patients. Geriatrics, 55 (2), 54-64.
9. Colley, C.A., & Lucas, L.M. (1993). Polypharmacy: The cure becomes the disease. Journal of General Internal Medicine, 8 (5), 278-83.
10. Cowley, A.J., & Elkeles, R.S. (1978). Diabetes and therapy with potent diuretics. Lancet, 1, 154.
11. de Leeuw, P.W., Notter, T., & Zilles, P. (1997). Comparison of different fixed antihypertensive combination drugs: A double blind, placebo-controlled parallel group study. Journal of Hypertension, 15, 87-91.
12. Dhond, A.J., Michelena, H.I., & Ezekowitz, M.D. (2003). Anticoagulation in the elderly. Americcan Journal of Geriatric Cardiology, 12(4), 243-250.
13. Fillit, H.M., Futterman, R., Orland, B.I., Chim, T., Susnow, L., Picariello, G.P., Scheye, E.C., Spoeri, R.K., Roglieri, J.L., & Warburton, S.W. (1999). Polypharmacy management in Medicare managed care: Changes in prescribing by primary care physicians resulting from a program promoting medication reviews. Americna Journal of Managed Care, 5 (5), 587-94.
14. Gaddis, G.M., Holt, T.R., & Woods, M. (2002). Drug interactions in at-risk emergency department patients. Academy of Emergency Medicine, 9 (11),1162-7.
15. Glynn, R.J., Monane, M., Gurwitz, J.H., Choodnovskiy, I., and Avorn, J. (1999). Aging, Comorbidity, and Reduced Rates of Drug Treatment for Diabetes Mellitus. Journal of Clinical Epidemiology, 52 (8), 781-790.
16. Golden, A.G., Preston, R.A., Barnett, S.D., Llorente, M., Hamdan, K., & Silverman, M.A. (1997). Inappropriate medication prescribing in homebound older adult. Journal of the American Geriatrics Society, 47 (8), 948-953.
17. Hanlon, J.T., Schmader, K.E., Koronkowski, M.J., Weinberger, M., Landsman, P.B., Samsa, G.P., & Lewis, I.K. (1997). Adverse drug events in high risk older outpatients. Journal of American Geriatric Society, 45 (8), 945-8.
18. Harrower, A.D. (2000). Comparative tolerability of sulphonylureas in diabetes mellitus. Drug Safety, 22 (4), 313-20.
19. Kupferberg, N., & Jones Hartel, L. (2004). Evaluation of five full-text drug databases by pharmacy students, faculty, and librarians: Do the groups agree? Journal of Medical Library Association, 92 (1), 66-71.
20. Langdorf, M.I., Fox, J.C., Marwah, R.S., Montague, B.J., & Hart, M.M. (2000). Physician versus computer knowledge of potential drug interactions in the emergency department. Acad Emerg Med., 7 (11), 1321-9.
21. Meredith, S., Feldman, P.H., Frey, D., Hall, K., Arnold, K., Brown, N.J., & Ray, W.A. (2001). Possible medication errors in home healthcare patients. Journal of American Geriatric Society, 49 (6), 719-24.
22. Reikvam, A., Madsen, S., & Landmark, K. (2003). [Secondary prevention after acute myocardial infarction: Aspirin, warfarin or both?]. Tidsskr Nor Laegeforen, 123 (13-14), 1838-40.
23. Sakurai, H., Kei, M., Matsubara, K., Yokouchi, K., Hattori, K., Ichihashi, R., Hirakawa, Y., Tsukamoto, H., & Saburi, Y. (2000). Cardiogenic shock triggered by verapamil and atenolol: A case report of therapeutic experience with intravenous calcium. Japan Circ Journal, 64 (11), 893-6.
24. Shaughnessy, P.W., Crisler, K.S., & Schlenker, R.E. (1993). Medicare OASIS: Standardized Outcome and Assessment Information Set for Home Health Care. Center for Health Service and Policy Research, Denver, Colorado.
25. Shorr, R.I., Ray, W.A., Daugherty, J.R., & Griffin, M.R. (1997). Incidence and risk factors for serious hypoglycemia in older persons using insulin or sulfonylureas. Archives of Internal Medicine, 157 (15), 1681-6.
26. Simonson, W. (1984). Medications & The Elderly: A Guide for Promoting Proper Use. An Aspen Publication.
27. Sone, H., Takahashi, A., & Yamada, N. (2001). Ibuprofen-related hypoglycemia in a patient receiving sulfonylurea. Annals Internal Medicine, 134 (4), 344.
28. Veehof, L., Stewart, R., Haaijer-Juskamp, F., & Jong, B.M. (2000). The development of polypharmacy. A longitudinal study. Family Practice, 17 (3), 261-267.
29. White, J.R. Jr., & Campbell, R.K. (1995). Drug/Drug and drug/disease interactions and diabetes. Diabetes Educ, 21 (4), 283-286.
30. Wolff, F.W., & Lindeman, R.D. (1966). Effects of treatment in hypertension: Results of a controlled study. Journal of Chronic Diseases, 19, 227.